S&P BSE Momentum Index Earnings/Conference Calls

S&P BSE Momentum Index earnings concalls and investor presentations

Load latest

Glenmark Pharmaceuticals Ltd.

19 Feb 2025

1398.20

-1.46%

Earnings Call

GLENMARK PHARMACEUTICALS LTD. - 532296 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

BSE India

Further to our letter dated 5th February, 2025 and pursuant to Regulation 30(6) read with Part A of Schedule III of SEBI (LODR), Regulations 2015, the transcript of the Earnings Call held on Monday, 17th February, 2025 for the third quarter ended December 31, 2024 has been uploaded on the Company''s website.

pdf

Persistent Systems Ltd.

18 Feb 2025

5443.00

-0.48%

Earnings Call

PERSISTENT SYSTEMS LTD. - 533179 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

BSE India

The Outcome of participation in a conference concluded on February 18, 2025 is as enclosed.

pdf

Mahindra & Mahindra Ltd.

18 Feb 2025

2982.10

-1.68%

Earnings Call

MAHINDRA & MAHINDRA LTD. - 500520 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - …

BSE India

This is further to our letters bearing REF:NS:SEC dated 3rd February, 2025 wherein we had given you an advance intimation of the Schedule of Analyst or Institutional Investor Meeting(s) with the Company in terms of Regulation 30(6) read with Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. We wish to inform you that the Company today physically participated in Kotak Conference in Mumbai with Several Funds/Investors (One on One/Group Meeting) and the Presentation(s) which was sent to the Stock Exchanges vide our letter bearing REF:NS:SEC dated 14th June, 2024 was shared with them. The aforesaid Conference was concluded at 6:00 p.m. IST. The aforesaid Presentation is also available on the Website of the Company at the Weblink: https://www.mahindra.com/sites/default/files/2024-06/Mahindra-Group-Investor-Day-Deck-14th-June-2024_0.pdf was shared with them. Please note that the Company has referred to publicly available documents for discussions and no unpublished price sensitive information has been shared during the aforesaid Conference.

pdf

Muthoot Finance Ltd.

18 Feb 2025

2229.60

0.35%

Earnings Call

MUTHOOT FINANCE LTD. - 533398 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

BSE India

Announcement under Regulation 30 (LODR) - Earnings call transcript

pdf

Indian Hotels Company Ltd.

18 Feb 2025

718.75

-4.17%

Investor Presentation

INDIAN HOTELS CO.LTD. - 500850 - Announcement under Regulation 30 (LODR)-Investor Presentation

BSE India

This has reference to Regulation 30(6) read with Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015 (the ''Regulations''). In furtherance to our letter dated January 23, 2025, please find attached the presentation to be made at the ''Kotak Chasing Growth Conference 2025'' to be held today.

pdf

Dixon Technologies (India) Ltd.

17 Feb 2025

15190.00

-2.79%

Earnings Call

Dixon Technologies (India) Ltd - 540699 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - …

BSE India

Pursuant to Regulations 30 and 46 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with Para A and Part A of schedule III of the said regulations, we hereby inform that the Company's officials had Meeting(s) with the enclosed analyst(s)/advisor(s)/investor(s).

pdf

Glenmark Pharmaceuticals Ltd.

17 Feb 2025

1398.20

-1.46%

Earnings Call

GLENMARK PHARMACEUTICALS LTD. - 532296 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

BSE India

Pursuant to the Regulation 30 and 46 read with Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, we hereby confirm that we have uploaded audio recording of Q3 FY 2024 - 25 Earnings Call held on 17th February, 2025 on the website of the Company.

pdf

Glenmark Pharmaceuticals Ltd.

17 Feb 2025

1398.20

-1.46%

Glenmark Pharmaceuticals Results Earnings Call for Q3FY25

Conference Call with Glenmark Pharmaceuticals Management and Analysts on Q3FY25 Performance and Outlook. Listen to the full earnings transcript.

Dixon Technologies (India) Ltd.

15 Feb 2025

15190.00

-2.79%

Earnings Call

Dixon Technologies (India) Ltd - 540699 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - …

BSE India

Pursuant to Regulations 30 and 46 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with Para A and Part A of schedule III of the said regulations, we hereby inform that the Company's officials had a Meeting with the analyst(s)/advisor(s)/investor(s) of Kotak Securities on 14th Feb, 2025.

pdf

Eicher Motors Ltd.

15 Feb 2025

5324.00

-0.90%

Earnings Call

EICHER MOTORS LTD. - 505200 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

BSE India

Earnings Call Transcript

pdf

S&P BSE Momentum Index PB	8.3
S&P BSE Momentum Index PE	40.3
S&P BSE Momentum Index DIV	0.9
S&P BSE Momentum Index EPS	49.9